Researchers discovered that COVID-19 and chronic hepatitis B share key genetic pathways related to the immune system. This ...

Republic of Korea # Virus Research and Testing Group, Korea Research Institute of Chemical Technology, Daejeon 305-600, Republic of Korea *S.S.K.: phone, +82-2-961-0524; fax, +82-2-959-8168; e-mail, ...

A model for hepatitis B virus-associated chronic liver disease has been made using cloned hepatitis B virus DNA as a transgene in a severe combined immunodeficient host. These mice consistently ...

Two key factors have enabled the development of the hepatitis B virus (HBV) vaccine (as reviewed in ref 1.): (1) identification of an immunogenic HBV protein that would stimulate the human immune ...

Normandie Univ, INSA Rouen, UNIROUEN, CNRS, COBRA (UMR 6014), 76000 Rouen, France ...

qBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan rCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan ...

and the hepatitis B virus (HBV) infection status of the participants was determined by the chemiluminescence immunoassay test. Univariate and multivariate analyses were applied to evaluate the ...

while also providing meaningful reductions in hepatitis B surface antigen and hepatitis B virus DNA. About AB-101 AB-101 is an oral PD-L1 inhibitor candidate that is designed to allow for ...

Not only is the hepatitis B virus responsible for 54% of liver cancer cases, but the Centers for Disease Control and Prevention (CDC) recommends that all adults aged 19-59 get vaccinated against ...

More apparent signs of infection, such as yellow eyes, may emerge later—but possibly only after a test for the virus starts showing as negative. Diseases similar to hepatitis A have been ...

This paper studies a system of equations modelling the dynamic of hepatitis B with age-dependent susceptibility in a closed population. Its manifestations in human body are shown by hepatitis B ...